Cansino Financial Statements From 2010 to 2024

Stocks . China . 
Stock . Cansino Biologics
688185 Stock   61.23  0.13  0.21%   
Cansino Biologics financial statements provide useful quarterly and yearly information to potential Cansino Biologics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cansino Biologics financial statements helps investors assess Cansino Biologics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cansino Biologics' valuation are summarized below:
Gross Profit
-183.7 M
Profit Margin
(0.96)
Market Capitalization
10.7 B
Enterprise Value Revenue
15.972
Revenue
748.5 M
We have found seventy-six available fundamental signals for Cansino Biologics, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Cansino Biologics prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Cansino Biologics Total Revenue

327.92 Million

Check Cansino Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cansino Biologics' main balance sheet or income statement drivers, such as Net Interest Income of 27.1 M, Interest Income of 105.1 M or Interest Expense of 67.4 M, as well as many indicators such as . Cansino financial statements analysis is a perfect complement when working with Cansino Biologics Valuation or Volatility modules.
  
This module can also supplement various Cansino Biologics Technical models . Check out the analysis of Cansino Biologics Correlation against competitors.

Cansino Biologics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.7 B9.3 B3.7 B
Slightly volatile
Other Current Liabilities769.2 M732.5 M247.7 M
Slightly volatile
Total Current Liabilities1.4 B2.6 B756.5 M
Slightly volatile
Total Stockholder Equity4.5 B5.3 B2.5 B
Slightly volatile
Other Liabilities134.3 M255.7 M92.5 M
Slightly volatile
Net Tangible Assets4.2 B7.5 B2.6 B
Slightly volatile
Net Debt499.3 M475.6 M229.5 M
Slightly volatile
Accounts Payable200.3 M104 M99.2 M
Slightly volatile
Cash2.5 B2 B1.2 B
Slightly volatile
Non Current Assets Total2.2 B4.1 B1.3 B
Slightly volatile
Non Currrent Assets Other417 M397.1 M149.3 M
Slightly volatile
Other Assets481.5 M458.5 M130.6 M
Slightly volatile
Long Term Debt1.1 B1.1 B289.3 M
Slightly volatile
Net Receivables668.7 M636.9 M158.5 M
Slightly volatile
Common Stock Shares Outstanding259.1 M284.6 M231.5 M
Slightly volatile
Short Term Investments1.4 B2.1 B860 M
Slightly volatile
Non Current Liabilities Total1.5 B1.4 B432.9 M
Slightly volatile
Inventory330.2 M350.7 M162.8 M
Slightly volatile
Other Current Assets181.3 M281.8 M97.6 M
Slightly volatile
Other Stockholder Equity103.5 K108.9 K6.1 M
Slightly volatile
Total Liabilities2.1 B4 B1.1 B
Slightly volatile
Deferred Long Term Liabilities41.5 M59.7 M31.8 M
Slightly volatile
Net Invested Capital5.5 B7.7 B3.1 B
Slightly volatile
Short and Long Term Debt1.5 B1.4 B371.9 M
Slightly volatile
Total Current Assets4.6 B5.2 B2.4 B
Slightly volatile
Net Working Capital3.1 B2.6 B1.7 B
Slightly volatile
Intangible Assets138.9 M205.6 M87.2 M
Slightly volatile
Common Stock235.1 M284.6 M193.1 M
Slightly volatile
Property Plant Equipment3.7 B3.5 B1.2 B
Slightly volatile
Capital Stock251.8 M284.6 M196.7 M
Slightly volatile
Property Plant And Equipment Net2.2 B3 B1.2 B
Slightly volatile
Capital Lease Obligations169.4 M239.8 M72.5 M
Slightly volatile
Property Plant And Equipment Gross2.5 B3.9 B1.3 B
Slightly volatile

Cansino Biologics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income27.1 M35.7 M13.4 M
Slightly volatile
Interest Income105.1 M100.1 M27.1 M
Slightly volatile
Selling General Administrative680.2 M647.8 M161.6 M
Slightly volatile
Other Operating Expenses4.8 M9.6 M3.1 M
Slightly volatile
Research Development480.4 M638 M267.6 M
Slightly volatile
Cost Of Revenue617.7 M1.2 B335 M
Slightly volatile
Total Operating Expenses1.3 B2.4 B675 M
Slightly volatile
Reconciled Depreciation282.5 M269.1 M64.7 M
Slightly volatile

Cansino Biologics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow2.1 B3 B1 B
Slightly volatile
Depreciation282.5 M269.1 M61.7 M
Slightly volatile
Dividends Paid60.8 M98.7 M34 M
Slightly volatile
Capital Expenditures574.7 M659.7 M358.9 M
Slightly volatile
Change To Operating Activities2.3 M2.4 M7.2 M
Very volatile
Total Cash From Financing Activities1.6 B982.4 M999.1 M
Slightly volatile
End Period Cash Flow2.5 B2.3 B1.2 B
Slightly volatile
Other Cashflows From Investing Activities129.4 M123.2 M48.2 M
Slightly volatile
Stock Based Compensation11 M9.5 M18.2 M
Slightly volatile

About Cansino Biologics Financial Statements

Cansino Biologics stakeholders use historical fundamental indicators, such as Cansino Biologics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Cansino Biologics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cansino Biologics' assets and liabilities are reflected in the revenues and expenses on Cansino Biologics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cansino Biologics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue345.2 M327.9 M
Cost Of Revenue1.2 B617.7 M

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Cansino Stock

Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY